Valuation: Ridgeback Resources Inc

Market Cap 181K 161K 150K 137K 257K 17.48M 260K 1.81M 706K 8.88M 678K 663K 28.57M P/E 2016
-1.88x
P/E 2017 -3.96x
Enterprise Value 1.31M 1.17M 1.09M 990K 1.86M 127M 1.88M 13.09M 5.12M 64.4M 4.91M 4.81M 207M EV / Sales 2016
60,329,081x
EV / Sales 2017 18,016,685x
Free-Float
24.19%
Yield 2016 *
-
Yield 2017 -
1 day-92.33%
1 week-98.26%
Current month-98.98%
1 month-93.52%
3 months-98.85%
6 months+820.00%
Current year+820.00%
1 week 0.02
Extreme 0.023
1.26
1 month 0.02
Extreme 0.023
3.95
Current year 0
Extreme 0.0025
5
1 year 0
Extreme 0.0025
5
3 years 0
Extreme 0.0025
5
5 years 0
Extreme 0.0025
8
10 years 0
Extreme 0.0025
126.88
Manager TitleAgeSince
Chief Executive Officer - -
General Counsel 77 -
Treasurer 72 -
Director TitleAgeSince
Director/Board Member 77 -
Director/Board Member - -
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
-92.33%-98.26%+820.00%-99.47% 933K
-0.17%+3.05%+14.13%+25.61% 112B
+1.33%+5.11%+4.40%+81.36% 96.35B
-1.21%-4.33%+127.08%+797.34% 56.33B
+0.50%-5.05%-12.46%+48.17% 26.23B
+0.71%+3.15%+13.22%+56.02% 25.48B
+1.65%-0.12%+27.60%+85.73% 25.48B
+0.26%+1.55%-16.65%-2.43% 21.32B
+0.28%+2.60%+29.97%+322.59% 20.98B
+2.61%+18.47%+11.12%+87.91% 19.83B
Average -8.64%+2.47%+101.84%+140.28% 40.43B
Weighted average by Cap. +0.44%+2.47%+25.67%+170.58%

Financials

2016 2017
Net sales 0.51 0.45 0.42 0.38 0.72 49.05 0.73 5.07 1.98 24.92 1.9 1.86 80.16 1.04 0.93 0.87 0.79 1.48 100.95 1.5 10.43 4.08 51.3 3.91 3.83 164.98
Net income -15.7M -14.02M -13.08M -11.88M -22.36M -1.52B -22.58M -157M -61.42M -773M -58.95M -57.67M -2.48B -4.25M -3.79M -3.54M -3.22M -6.05M -412M -6.11M -42.5M -16.62M -209M -15.95M -15.61M -673M
Net Debt 355K 317K 296K 269K 506K 34.38M 510K 3.55M 1.39M 17.47M 1.33M 1.3M 56.19M 1.13M 1.01M 940K 854K 1.61M 109M 1.62M 11.28M 4.41M 55.51M 4.24M 4.14M 179M
Logo Ridgeback Resources Inc
Ridgeback Resources, Inc., formerly Columbine Valley Resources, Inc., is engaged in the business of performing non-invasive ultrasound scans of carotid arteries. The Company is also engaged in producing medical grade reports that evaluate the level of atherosclerotic disease (aka plaque). The report presents detailed information about the presence or absence of atherosclerotic disease.
Employees
7
Date Price Change Volume
26-10-07 US$1.200 -4.00% 800
26-10-06 US$1.250 -5.30% 760
  1. Stock Market
  2. Stocks
  3. RBRS Stock